Report Overview

The rising prevalence of diabetes across the country, growing awareness and early diagnosis about the disorder, and an increasing focus on diabetes management are expected to drive India Blood Glucose Monitor Device Market during the forecast period between 2025 and 2031.

India Blood Glucose Monitor Device Market – Industry Trends & Forecast Report, 2031

India Blood Glucose Monitor Device Market size was estimated at USD 446.8 million in 2024. During the forecast period between 2025 and 2031, India Blood Glucose Monitor Device Market size is projected to grow at a CAGR of 10.2% reaching a value of USD 889.3 million by 2031. Prominent drivers of the market include the rising prevalence of diabetes, increasing awareness, higher diagnosis rates, and technological advancements in diabetes management. According to the ICMR INDIAB study (2023), India recorded 10.1 crore diabetes cases, with the International Diabetes Federation (2022) projecting this number to reach 124.2 million by 2045. Awareness campaigns, such as Roche Diabetes Care India’s 2023 initiative during World Diabetes Day, are enhancing early diagnosis and management, thereby driving demand. Additionally, technological innovations like IoT-enabled wearable devices for non-invasive glucose monitoring are gaining traction. Local manufacturing efforts, such as Roche’s Accu-Chek Active with Bluetooth connectivity, further support market growth by offering convenient monitoring solutions. These factors collectively position the market for robust expansion over the forecast period.

Blood Glucose Monitor Device – Overview

A blood glucose monitor device is a medical device designed to measure and display the concentration of glucose in the blood. These devices are primarily used by individuals with diabetes to monitor and manage their blood sugar levels effectively. Typically, they consist of a small handheld unit, a lancet for obtaining a blood sample, and test strips that react with the blood to provide a glucose reading. Modern advancements include non-invasive or minimally invasive devices, continuous glucose monitoring (CGM) systems, and devices integrated with smartphone applications for real-time tracking and data management, enhancing convenience and accuracy for users.

India Blood Glucose Monitor Device Market

Growth Drivers

Growing Awareness about Diabetes and Early Diagnosis

Diabetes is a chronic condition caused by insufficient insulin production or the body's inability to utilize insulin effectively, resulting in elevated blood sugar levels (hyperglycemia). If left uncontrolled, it can lead to severe complications such as nerve damage, cardiovascular issues, diabetic retinopathy, kidney failure, and even limb amputation. In India, approximately 77 million adults over the age of 18 have type 2 diabetes, and nearly 25 million are prediabetic, placing them at a higher risk of developing the disease. Alarmingly, over 50% of individuals remain unaware of their diabetic status, increasing the likelihood of undetected health complications. Early diagnosis and timely intervention are crucial to managing diabetes effectively and preventing long-term damage. Rising awareness campaigns and early detection efforts are playing a pivotal role in addressing these challenges. As more individuals recognize the importance of monitoring blood glucose levels, the demand for blood glucose monitoring devices has surged. These devices enable early diagnosis and effective management, reducing the risks of severe complications and improving quality of life. Consequently, the growing emphasis on awareness and early detection is significantly driving the expansion of the India Blood Glucose Monitor Device Market.

Challenges

High Costs

The high cost of blood glucose monitoring devices and consumables significantly restrains the growth of the market in India. Financial constraints, particularly in rural and remote areas, limit adherence to self-monitoring guidelines due to the unavailability of affordable glucose monitoring strips and advanced devices like continuous glucose monitors (CGMs). The lack of awareness about newer technologies and their high costs further restrict adoption. Additionally, the scarcity of specialists and limited access to advanced diagnostic laboratories exacerbate the situation, as patients often face an unsustainable financial burden for consultations and testing required for regular monitoring. These challenges hinder effective diabetes management, underscoring the need for collaboration between healthcare professionals and policymakers to enhance accessibility, affordability, and awareness of glucose monitoring solutions while ensuring adherence to national and international guidelines.

Impact of Escalating Geopolitical Tensions on India Blood Glucose Monitor Device Market

Escalating geopolitical tensions could significantly impact India Blood Glucose Monitor Device Market. Disruptions in global supply chains, driven by conflicts or trade restrictions, can lead to shortages of raw materials and components required for manufacturing these devices. Additionally, increased import costs due to currency fluctuations and tariffs can raise the prices of advanced monitoring devices, making them less affordable for consumers. Tensions can also affect collaborations and investments in medical technology, slowing the introduction of innovative solutions like continuous glucose monitors. These challenges, coupled with India's existing issues of affordability and accessibility, may hinder the market's growth. Addressing these impacts requires proactive policy measures and diversification of supply chains to ensure market stability.

India Blood Glucose Monitor Device Market

Segmental Coverage

India Blood Glucose Monitor Device Market – By Product

Based on product, India Blood Glucose Monitor Device Market is bifurcated into Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices segments. The self-monitoring devices segment holds a higher share in India Blood Glucose Monitor Device Market by product. Self-monitoring blood glucose (SMBG) devices enable individuals to independently monitor their glucose levels, offering flexibility and quick turnaround times. These devices are widely adopted by patients and recommended by healthcare professionals, supported by guidelines from authorities like the Indian Council of Medical Research (ICMR). According to these guidelines, SMBG is beneficial for managing diabetes, especially for individuals on insulin therapy, at risk of hypoglycemia, or requiring tight glycemic control. Additionally, market players are driving growth through strategic initiatives, such as Roche Diabetes Care India’s local manufacturing of 'Accu-Chek Active.' These factors collectively propel segment expansion over the forecast period.

India Blood Glucose Monitor Device Market – By End Use

By end use, India Blood Glucose Monitor Device Market is divided into Hospitals, Home Care, and Diagnostic Centers segments. The hospitals segment holds the largest share of India Blood Glucose Monitor Device Market by end use. Hospitals are key settings for utilizing blood glucose monitoring devices, especially for critically ill patients. In India, hospitals and clinics offer affordable care for diabetic patients, which has led to the widespread adoption of these devices in healthcare facilities. This segment is further growing due to the availability of specialized staff and government initiatives supporting diabetes care. The integration of advanced technologies, such as artificial intelligence (AI), is driving the segment’s expansion. For example, AI-powered applications like the Dexcom G6, used in hospitals, help manage glucose levels in diabetic patients by automating insulin suspension and preventing hypoglycemia. Additionally, strategic initiatives by market players, such as MFine’s AI-driven blood glucose and blood pressure monitoring through smartphones, are expected to further stimulate growth in this segment.

India Blood Glucose Monitor Device Market – By Region

The in-depth research report on India Blood Glucose Monitor Device Market covers the market in the country’s major regions: North India, South India, East India, and West India regions. West India holds the highest share in India Blood Glucose Monitor Device Market and is expected to maintain its dominance during the forecast period. The region, particularly driven by states like Maharashtra and Gujarat, benefits from a higher prevalence of diabetes, advanced healthcare infrastructure, and growing awareness about the importance of glucose self-monitoring. These factors lead to increased adoption of glucose monitoring devices, boosting market growth. Additionally, cities like Mumbai and Ahmedabad, known for their healthcare innovation, are hubs for introducing advanced glucose monitoring technologies. Government initiatives to promote diabetes management, such as awareness campaigns and subsidized services, further support the market's growth in this region. With the rising demand for proactive healthcare, West India presents significant opportunities for manufacturers and suppliers.

Competitive Landscape

Major players operating in India Blood Glucose Monitor Device Market include Abbott Laboratories, Roche Diagnostics, Johnson & Johnson, Medtronic, Dexcom, Ascensia Diabetes Care, Nipro Corporation, Becton, Dickinson and Company (BD), Terumo Corporation, and Arkray Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In July 2024 - Fitterfly entered into a strategic partnership with Ascensia Diabetes Care to integrate Ascensia's advanced Bluetooth-enabled Contour Plus Elite glucometer into Fitterfly's diabetes management kits and app. This collaboration was designed to enhance how program members manage their diabetes.

• In November 2023 - Roche Diabetes Care India joined forces with both public and private healthcare stakeholders in India to improve access to diabetes care. Their efforts focused on raising awareness, promoting education, and facilitating early diagnosis, alongside ensuring ongoing care through impactful collaborations with key partners.

Scope of the Report

By Product

• Self-monitoring Devices

• Continuous Blood Glucose Monitoring Devices

By End Use

• Hospitals

• Home Care

• Diagnostic Centers

By Region

• North India

• South India

• East India

• West India